nodes	percent_of_prediction	percent_of_DWPC	metapath
Salicylate-sodium—Distention—Metformin—polycystic ovary syndrome	0.0726	0.137	CcSEcCtD
Salicylate-sodium—PTGS2—ovarian follicle—polycystic ovary syndrome	0.0683	0.383	CbGeAlD
Salicylate-sodium—Abdominal bloating—Metformin—polycystic ovary syndrome	0.0359	0.0679	CcSEcCtD
Salicylate-sodium—Epigastric discomfort—Metformin—polycystic ovary syndrome	0.0325	0.0615	CcSEcCtD
Salicylate-sodium—Acidosis—Metformin—polycystic ovary syndrome	0.0309	0.0584	CcSEcCtD
Salicylate-sodium—PTGS2—Nicotinate metabolism—NMNAT3—polycystic ovary syndrome	0.0279	0.113	CbGpPWpGaD
Salicylate-sodium—Upset stomach—Metformin—polycystic ovary syndrome	0.0261	0.0493	CcSEcCtD
Salicylate-sodium—Heartburn—Metformin—polycystic ovary syndrome	0.0249	0.047	CcSEcCtD
Salicylate-sodium—Acetylsalicylic acid—AKR1C1—polycystic ovary syndrome	0.0214	0.475	CrCbGaD
Salicylate-sodium—Salicylic acid—AKR1C1—polycystic ovary syndrome	0.0177	0.391	CrCbGaD
Salicylate-sodium—PTGS2—Nicotinamide salvaging—NAMPT—polycystic ovary syndrome	0.0174	0.0703	CbGpPWpGaD
Salicylate-sodium—Lightheadedness—Metformin—polycystic ovary syndrome	0.0153	0.0289	CcSEcCtD
Salicylate-sodium—Renal impairment—Metformin—polycystic ovary syndrome	0.013	0.0247	CcSEcCtD
Salicylate-sodium—Lethargy—Metformin—polycystic ovary syndrome	0.0127	0.0239	CcSEcCtD
Salicylate-sodium—Dehydration—Metformin—polycystic ovary syndrome	0.0115	0.0218	CcSEcCtD
Salicylate-sodium—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.0113	0.0214	CcSEcCtD
Salicylate-sodium—Abdominal distension—Metformin—polycystic ovary syndrome	0.0108	0.0204	CcSEcCtD
Salicylate-sodium—PTGS1—Prostaglandin Synthesis and Regulation—PTGER3—polycystic ovary syndrome	0.0105	0.0424	CbGpPWpGaD
Salicylate-sodium—Sweating increased—Metformin—polycystic ovary syndrome	0.0105	0.0198	CcSEcCtD
Salicylate-sodium—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.0103	0.0194	CcSEcCtD
Salicylate-sodium—Drowsiness—Metformin—polycystic ovary syndrome	0.00957	0.0181	CcSEcCtD
Salicylate-sodium—PTGS2—Nicotinate metabolism—NAMPT—polycystic ovary syndrome	0.00925	0.0374	CbGpPWpGaD
Salicylate-sodium—PTGS2—embryo—polycystic ovary syndrome	0.00923	0.0518	CbGeAlD
Salicylate-sodium—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—AKR1C3—polycystic ovary syndrome	0.00896	0.0362	CbGpPWpGaD
Salicylate-sodium—Hepatitis—Metformin—polycystic ovary syndrome	0.00859	0.0162	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00855	0.0161	CcSEcCtD
Salicylate-sodium—PTGS2—Prostaglandin Synthesis and Regulation—PTGER3—polycystic ovary syndrome	0.00833	0.0337	CbGpPWpGaD
Salicylate-sodium—PTGS2—adrenal cortex—polycystic ovary syndrome	0.00756	0.0424	CbGeAlD
Salicylate-sodium—Erythema—Metformin—polycystic ovary syndrome	0.00748	0.0141	CcSEcCtD
Salicylate-sodium—Flatulence—Metformin—polycystic ovary syndrome	0.00737	0.0139	CcSEcCtD
Salicylate-sodium—Dysgeusia—Metformin—polycystic ovary syndrome	0.00732	0.0138	CcSEcCtD
Salicylate-sodium—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—AKR1C3—polycystic ovary syndrome	0.00711	0.0288	CbGpPWpGaD
Salicylate-sodium—PTGS1—endometrium—polycystic ovary syndrome	0.00707	0.0396	CbGeAlD
Salicylate-sodium—Vision blurred—Metformin—polycystic ovary syndrome	0.00705	0.0133	CcSEcCtD
Salicylate-sodium—PTGS2—endometrium—polycystic ovary syndrome	0.00675	0.0379	CbGeAlD
Salicylate-sodium—Syncope—Metformin—polycystic ovary syndrome	0.00671	0.0127	CcSEcCtD
Salicylate-sodium—Palpitations—Metformin—polycystic ovary syndrome	0.00661	0.0125	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00657	0.0124	CcSEcCtD
Salicylate-sodium—PTGS1—uterus—polycystic ovary syndrome	0.00651	0.0365	CbGeAlD
Salicylate-sodium—PTGS1—pituitary gland—polycystic ovary syndrome	0.00639	0.0359	CbGeAlD
Salicylate-sodium—PTGS1—adipose tissue—polycystic ovary syndrome	0.00637	0.0357	CbGeAlD
Salicylate-sodium—Chest pain—Metformin—polycystic ovary syndrome	0.00637	0.012	CcSEcCtD
Salicylate-sodium—PTGS2—uterus—polycystic ovary syndrome	0.00622	0.0349	CbGeAlD
Salicylate-sodium—PTGS2—pituitary gland—polycystic ovary syndrome	0.00611	0.0343	CbGeAlD
Salicylate-sodium—Oedema—Metformin—polycystic ovary syndrome	0.0061	0.0115	CcSEcCtD
Salicylate-sodium—PTGS2—adipose tissue—polycystic ovary syndrome	0.00609	0.0342	CbGeAlD
Salicylate-sodium—Infection—Metformin—polycystic ovary syndrome	0.00606	0.0115	CcSEcCtD
Salicylate-sodium—Mesalazine—PPARG—polycystic ovary syndrome	0.00601	0.133	CrCbGaD
Salicylate-sodium—Shock—Metformin—polycystic ovary syndrome	0.006	0.0113	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.0059	0.0111	CcSEcCtD
Salicylate-sodium—Anorexia—Metformin—polycystic ovary syndrome	0.00582	0.011	CcSEcCtD
Salicylate-sodium—PTGS1—adrenal gland—polycystic ovary syndrome	0.00571	0.0321	CbGeAlD
Salicylate-sodium—Hypotension—Metformin—polycystic ovary syndrome	0.0057	0.0108	CcSEcCtD
Salicylate-sodium—Paraesthesia—Metformin—polycystic ovary syndrome	0.00548	0.0104	CcSEcCtD
Salicylate-sodium—PTGS2—adrenal gland—polycystic ovary syndrome	0.00546	0.0306	CbGeAlD
Salicylate-sodium—Dyspnoea—Metformin—polycystic ovary syndrome	0.00544	0.0103	CcSEcCtD
Salicylate-sodium—Somnolence—Metformin—polycystic ovary syndrome	0.00543	0.0103	CcSEcCtD
Salicylate-sodium—Dyspepsia—Metformin—polycystic ovary syndrome	0.00537	0.0102	CcSEcCtD
Salicylate-sodium—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—NMNAT3—polycystic ovary syndrome	0.00533	0.0215	CbGpPWpGaD
Salicylate-sodium—PTGS1—female gonad—polycystic ovary syndrome	0.00533	0.0299	CbGeAlD
Salicylate-sodium—Decreased appetite—Metformin—polycystic ovary syndrome	0.00531	0.01	CcSEcCtD
Salicylate-sodium—PTGS1—vagina—polycystic ovary syndrome	0.00529	0.0297	CbGeAlD
Salicylate-sodium—Fatigue—Metformin—polycystic ovary syndrome	0.00526	0.00994	CcSEcCtD
Salicylate-sodium—Constipation—Metformin—polycystic ovary syndrome	0.00522	0.00986	CcSEcCtD
Salicylate-sodium—PTGS1—Prostaglandin Synthesis and Regulation—CYP11A1—polycystic ovary syndrome	0.00516	0.0208	CbGpPWpGaD
Salicylate-sodium—PTGS2—female gonad—polycystic ovary syndrome	0.00509	0.0286	CbGeAlD
Salicylate-sodium—PTGS2—vagina—polycystic ovary syndrome	0.00506	0.0284	CbGeAlD
Salicylate-sodium—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00503	0.0095	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00499	0.00943	CcSEcCtD
Salicylate-sodium—PTGS1—endocrine gland—polycystic ovary syndrome	0.00495	0.0278	CbGeAlD
Salicylate-sodium—Urticaria—Metformin—polycystic ovary syndrome	0.00485	0.00916	CcSEcCtD
Salicylate-sodium—Abdominal pain—Metformin—polycystic ovary syndrome	0.00482	0.00912	CcSEcCtD
Salicylate-sodium—PTGS2—endocrine gland—polycystic ovary syndrome	0.00473	0.0266	CbGeAlD
Salicylate-sodium—PTGS1—Overview of nanoparticle effects—BAX—polycystic ovary syndrome	0.00453	0.0183	CbGpPWpGaD
Salicylate-sodium—Asthenia—Metformin—polycystic ovary syndrome	0.00438	0.00827	CcSEcCtD
Salicylate-sodium—Pruritus—Metformin—polycystic ovary syndrome	0.00432	0.00816	CcSEcCtD
Salicylate-sodium—Diarrhoea—Metformin—polycystic ovary syndrome	0.00418	0.00789	CcSEcCtD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—PTCRA—polycystic ovary syndrome	0.00415	0.0168	CbGpPWpGaD
Salicylate-sodium—PTGS2—Prostaglandin Synthesis and Regulation—CYP11A1—polycystic ovary syndrome	0.00409	0.0165	CbGpPWpGaD
Salicylate-sodium—Dizziness—Metformin—polycystic ovary syndrome	0.00404	0.00763	CcSEcCtD
Salicylate-sodium—PTGS1—Overview of nanoparticle effects—CRP—polycystic ovary syndrome	0.00391	0.0158	CbGpPWpGaD
Salicylate-sodium—Vomiting—Metformin—polycystic ovary syndrome	0.00388	0.00733	CcSEcCtD
Salicylate-sodium—PTGS1—Prostaglandin Synthesis and Regulation—PRL—polycystic ovary syndrome	0.00385	0.0156	CbGpPWpGaD
Salicylate-sodium—Rash—Metformin—polycystic ovary syndrome	0.00385	0.00727	CcSEcCtD
Salicylate-sodium—Dermatitis—Metformin—polycystic ovary syndrome	0.00384	0.00726	CcSEcCtD
Salicylate-sodium—Headache—Metformin—polycystic ovary syndrome	0.00382	0.00722	CcSEcCtD
Salicylate-sodium—Nausea—Metformin—polycystic ovary syndrome	0.00363	0.00685	CcSEcCtD
Salicylate-sodium—PTGS2—Overview of nanoparticle effects—BAX—polycystic ovary syndrome	0.0036	0.0145	CbGpPWpGaD
Salicylate-sodium—PTGS1—Arachidonic acid metabolism—AKR1C3—polycystic ovary syndrome	0.00324	0.0131	CbGpPWpGaD
Salicylate-sodium—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—polycystic ovary syndrome	0.00318	0.0129	CbGpPWpGaD
Salicylate-sodium—PTGS2—Overview of nanoparticle effects—CRP—polycystic ovary syndrome	0.0031	0.0125	CbGpPWpGaD
Salicylate-sodium—PTGS2—Prostaglandin Synthesis and Regulation—PRL—polycystic ovary syndrome	0.00306	0.0124	CbGpPWpGaD
Salicylate-sodium—PTGS2—Signaling mediated by p38-alpha and p38-beta—ATF1—polycystic ovary syndrome	0.00295	0.0119	CbGpPWpGaD
Salicylate-sodium—PTGS1—Overview of nanoparticle effects—BCL2—polycystic ovary syndrome	0.00276	0.0112	CbGpPWpGaD
Salicylate-sodium—PTGS2—Arachidonic acid metabolism—AKR1C3—polycystic ovary syndrome	0.00257	0.0104	CbGpPWpGaD
Salicylate-sodium—PTGS1—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.0024	0.00971	CbGpPWpGaD
Salicylate-sodium—PTGS1—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.00223	0.00902	CbGpPWpGaD
Salicylate-sodium—PTGS2—Overview of nanoparticle effects—BCL2—polycystic ovary syndrome	0.00219	0.00885	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—INSR—polycystic ovary syndrome	0.00217	0.00876	CbGpPWpGaD
Salicylate-sodium—PTGS1—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.00203	0.00821	CbGpPWpGaD
Salicylate-sodium—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—polycystic ovary syndrome	0.00188	0.0076	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—PLAT—polycystic ovary syndrome	0.00187	0.00754	CbGpPWpGaD
Salicylate-sodium—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—NAMPT—polycystic ovary syndrome	0.00177	0.00715	CbGpPWpGaD
Salicylate-sodium—PTGS1—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00177	0.00714	CbGpPWpGaD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—CYP1A1—polycystic ovary syndrome	0.00172	0.00697	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—INSR—polycystic ovary syndrome	0.00172	0.00695	CbGpPWpGaD
Salicylate-sodium—PTGS2—S1P1 pathway—VEGFA—polycystic ovary syndrome	0.00164	0.00662	CbGpPWpGaD
Salicylate-sodium—PTGS2—Arachidonic acid metabolism—CYP1A1—polycystic ovary syndrome	0.00161	0.00652	CbGpPWpGaD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—CCNB1—polycystic ovary syndrome	0.00149	0.00602	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—PLAT—polycystic ovary syndrome	0.00148	0.00599	CbGpPWpGaD
Salicylate-sodium—PTGS1—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.00144	0.00582	CbGpPWpGaD
Salicylate-sodium—PTGS1—Overview of nanoparticle effects—IL6—polycystic ovary syndrome	0.00143	0.00577	CbGpPWpGaD
Salicylate-sodium—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.00142	0.00576	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.00137	0.00552	CbGpPWpGaD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—TAB1—polycystic ovary syndrome	0.00135	0.00547	CbGpPWpGaD
Salicylate-sodium—PTGS1—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.00128	0.00516	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—FST—polycystic ovary syndrome	0.00124	0.005	CbGpPWpGaD
Salicylate-sodium—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—polycystic ovary syndrome	0.00122	0.00493	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—MTHFR—polycystic ovary syndrome	0.00121	0.00487	CbGpPWpGaD
Salicylate-sodium—PTGS1—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.00119	0.00479	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—CRP—polycystic ovary syndrome	0.00115	0.00464	CbGpPWpGaD
Salicylate-sodium—PTGS2—Overview of nanoparticle effects—IL6—polycystic ovary syndrome	0.00113	0.00458	CbGpPWpGaD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—NCOR1—polycystic ovary syndrome	0.00112	0.00454	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—LPCAT2—polycystic ovary syndrome	0.00108	0.00438	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.00108	0.00437	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.00108	0.00437	CbGpPWpGaD
Salicylate-sodium—PTGS1—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.00106	0.00429	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—NGFR—polycystic ovary syndrome	0.00103	0.00417	CbGpPWpGaD
Salicylate-sodium—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—polycystic ovary syndrome	0.000966	0.0039	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—INS—polycystic ovary syndrome	0.000959	0.00388	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—MTHFR—polycystic ovary syndrome	0.000957	0.00387	CbGpPWpGaD
Salicylate-sodium—PTGS1—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000938	0.00379	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—CRP—polycystic ovary syndrome	0.00091	0.00368	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000905	0.00366	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—SERPINE1—polycystic ovary syndrome	0.000881	0.00356	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000858	0.00347	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—AKR1C2—polycystic ovary syndrome	0.000857	0.00347	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—TEAD2—polycystic ovary syndrome	0.000857	0.00347	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—TOP2A—polycystic ovary syndrome	0.000857	0.00346	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000819	0.00331	CbGpPWpGaD
Salicylate-sodium—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—polycystic ovary syndrome	0.000808	0.00327	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—INS—polycystic ovary syndrome	0.000761	0.00308	CbGpPWpGaD
Salicylate-sodium—PTGS1—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000756	0.00306	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000719	0.0029	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—LEP—polycystic ovary syndrome	0.000705	0.00285	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—SERPINE1—polycystic ovary syndrome	0.000699	0.00283	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000696	0.00281	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000681	0.00275	CbGpPWpGaD
Salicylate-sodium—PTGS2—C-MYB transcription factor network—BCL2—polycystic ovary syndrome	0.000667	0.0027	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	0.000666	0.00269	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—NMNAT3—polycystic ovary syndrome	0.000665	0.00269	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.00065	0.00263	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000635	0.00257	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—NMNAT3—polycystic ovary syndrome	0.000631	0.00255	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.00062	0.00251	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—SUOX—polycystic ovary syndrome	0.000609	0.00246	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—LPCAT2—polycystic ovary syndrome	0.000609	0.00246	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000601	0.00243	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	0.000568	0.00229	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ISYNA1—polycystic ovary syndrome	0.000566	0.00229	CbGpPWpGaD
Salicylate-sodium—PTGS1—Biological oxidations—POMC—polycystic ovary syndrome	0.000564	0.00228	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000553	0.00224	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000553	0.00223	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—NMNAT3—polycystic ovary syndrome	0.000528	0.00213	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000516	0.00209	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000504	0.00204	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000492	0.00199	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.00049	0.00198	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—SUOX—polycystic ovary syndrome	0.000483	0.00195	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—LPCAT2—polycystic ovary syndrome	0.000483	0.00195	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—AKR1C2—polycystic ovary syndrome	0.000481	0.00194	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—TEAD2—polycystic ovary syndrome	0.000481	0.00194	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000477	0.00193	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000463	0.00187	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000455	0.00184	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ISYNA1—polycystic ovary syndrome	0.000449	0.00182	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000439	0.00177	CbGpPWpGaD
Salicylate-sodium—PTGS1—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.000419	0.00169	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.00041	0.00166	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PNPLA2—polycystic ovary syndrome	0.000403	0.00163	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	0.000396	0.0016	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000389	0.00157	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—SRD5A1—polycystic ovary syndrome	0.000382	0.00154	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000382	0.00154	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—TEAD2—polycystic ovary syndrome	0.000382	0.00154	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000367	0.00148	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—STAR—polycystic ovary syndrome	0.000365	0.00147	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000361	0.00146	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.00036	0.00146	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	0.000346	0.0014	CbGpPWpGaD
Salicylate-sodium—PTGS2—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.000333	0.00134	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—HMMR—polycystic ovary syndrome	0.000325	0.00131	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—RPL37A—polycystic ovary syndrome	0.000325	0.00131	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PNPLA2—polycystic ovary syndrome	0.00032	0.00129	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—HSD3B1—polycystic ovary syndrome	0.00031	0.00125	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—HMMR—polycystic ovary syndrome	0.000308	0.00124	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000306	0.00124	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000303	0.00123	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.00029	0.00117	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—STAR—polycystic ovary syndrome	0.000289	0.00117	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000286	0.00116	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—LHB—polycystic ovary syndrome	0.000283	0.00114	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—HSD3B2—polycystic ovary syndrome	0.000276	0.00112	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—AKR1C1—polycystic ovary syndrome	0.000268	0.00108	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—IL6—polycystic ovary syndrome	0.000263	0.00106	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	0.000259	0.00105	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—HMMR—polycystic ovary syndrome	0.000258	0.00104	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—AKR1C1—polycystic ovary syndrome	0.000254	0.00103	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—SULT2A1—polycystic ovary syndrome	0.000246	0.000995	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—HSD3B1—polycystic ovary syndrome	0.000246	0.000995	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000243	0.000983	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—RRM2—polycystic ovary syndrome	0.000238	0.000964	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—FGF18—polycystic ovary syndrome	0.000235	0.000951	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—RBP4—polycystic ovary syndrome	0.000233	0.000944	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000231	0.000932	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—YAP1—polycystic ovary syndrome	0.00023	0.000929	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—LHB—polycystic ovary syndrome	0.000224	0.000907	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—NAMPT—polycystic ovary syndrome	0.000221	0.000893	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.00022	0.000888	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—HSD3B2—polycystic ovary syndrome	0.000219	0.000887	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CYP11A1—polycystic ovary syndrome	0.000218	0.000882	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000217	0.000875	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—GAB1—polycystic ovary syndrome	0.000215	0.000869	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—AKR1C1—polycystic ovary syndrome	0.000212	0.000859	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—NAMPT—polycystic ovary syndrome	0.000209	0.000846	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—AKR1C3—polycystic ovary syndrome	0.000206	0.000833	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CYP17A1—polycystic ovary syndrome	0.000203	0.00082	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—SULT2A1—polycystic ovary syndrome	0.000195	0.00079	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—AKR1C3—polycystic ovary syndrome	0.000195	0.000789	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—TNRC6B—polycystic ovary syndrome	0.000192	0.000777	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—RRM2—polycystic ovary syndrome	0.000189	0.000765	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—YAP1—polycystic ovary syndrome	0.000183	0.000738	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—TH—polycystic ovary syndrome	0.000175	0.000709	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—NAMPT—polycystic ovary syndrome	0.000175	0.000709	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	0.000174	0.000705	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CYP11A1—polycystic ovary syndrome	0.000173	0.0007	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	0.000172	0.000695	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—SLC2A4—polycystic ovary syndrome	0.000171	0.00069	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—TCF7L2—polycystic ovary syndrome	0.000165	0.000665	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—AKR1C3—polycystic ovary syndrome	0.000164	0.000661	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—SLC2A4—polycystic ovary syndrome	0.000162	0.000654	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CYP17A1—polycystic ovary syndrome	0.000161	0.000651	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CYP19A1—polycystic ovary syndrome	0.00016	0.000649	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PRL—polycystic ovary syndrome	0.000154	0.000624	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GNAS—polycystic ovary syndrome	0.000143	0.000579	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—TH—polycystic ovary syndrome	0.000139	0.000563	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—NCOR1—polycystic ovary syndrome	0.000136	0.000552	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—SLC2A4—polycystic ovary syndrome	0.000136	0.000548	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CYP1A1—polycystic ovary syndrome	0.000129	0.000523	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—NCOR1—polycystic ovary syndrome	0.000129	0.000523	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CYP19A1—polycystic ovary syndrome	0.000127	0.000515	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—NRG1—polycystic ovary syndrome	0.000127	0.000513	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—MTHFR—polycystic ovary syndrome	0.000121	0.000487	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—MTHFR—polycystic ovary syndrome	0.000114	0.000462	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GNAS—polycystic ovary syndrome	0.000114	0.00046	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—IRS2—polycystic ovary syndrome	0.000109	0.00044	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—NCOR1—polycystic ovary syndrome	0.000108	0.000438	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CYP1A1—polycystic ovary syndrome	0.000103	0.000415	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PPARG—polycystic ovary syndrome	9.78e-05	0.000395	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—POMC—polycystic ovary syndrome	9.64e-05	0.00039	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—INS—polycystic ovary syndrome	9.59e-05	0.000388	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—MTHFR—polycystic ovary syndrome	9.57e-05	0.000387	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—IRS1—polycystic ovary syndrome	9.49e-05	0.000384	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—INS—polycystic ovary syndrome	9.09e-05	0.000367	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—AKT2—polycystic ovary syndrome	8.79e-05	0.000355	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—SERPINE1—polycystic ovary syndrome	8.35e-05	0.000338	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PPARG—polycystic ovary syndrome	7.76e-05	0.000314	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—POMC—polycystic ovary syndrome	7.66e-05	0.000309	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—INS—polycystic ovary syndrome	7.61e-05	0.000308	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—IL6—polycystic ovary syndrome	3.97e-05	0.000161	CbGpPWpGaD
